Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus

S A Bishop1, N A Williams, T J Gruffydd-Jones

  • 1Department of Veterinary Medicine, University of Bristol, UK.

Insights

Feline immunodeficiency virus (FIV) infection impairs the ability of naive CD4+ T-helper cells to respond to new antigens. This defect in T-cell priming in FIV-infected cats may explain their increased susceptibility to opportunistic infections.

Area of Science:

  • Veterinary Immunology
  • Feline Infectious Diseases
  • Cellular Immunology

Background:

  • Feline immunodeficiency virus (FIV) infection leads to increased susceptibility to opportunistic pathogens.
  • Previous studies identified immunological abnormalities in FIV-infected cats but lacked detail on cellular dysfunction.
  • A gap exists in understanding defects in antigen-specific immune responses in FIV-infected cats.

Purpose of the Study:

  • To investigate the capacity of FIV-infected cats to mount an immune response to novel antigens.
  • To compare the development of antigen-specific cellular immunity during T-cell priming in uninfected and FIV-infected cats.

Main Methods:

  • Assessed general immune status using CD4+:CD8+ lymphocyte ratios and mitogen blastogenesis.
  • Developed an autologous culture system to measure in vitro T-cell priming to soluble antigen.
  • Compared T-cell priming in uninfected cats and cats infected with FIV for 6-27 months.

Main Results:

  • FIV-infected cats exhibited inverted CD4+:CD8+ lymphocyte ratios and impaired lymphocyte blastogenesis.
  • Naive CD4+ T-cells from FIV-infected cats showed significantly impaired priming to keyhole limpet haemocyanin (KLH).
  • Antigen-specific T-cell priming was significantly reduced in FIV-infected cats compared to controls.

Conclusions:

  • Impaired priming of naive CD4+ T-helper cells to antigen in FIV-infected cats likely contributes to their susceptibility to opportunistic infections.
  • This T-cell priming defect may also explain poor humoral immunity following vaccination in human AIDS patients.
Abstract